Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where ya off to?
TRDX looking like a tug of war....Bid against Ask
Don't know them, i just play them. See the volume and acivity yesterday on ABVV?
Move into ILVC bro!
GLER ----> Global Earth Energy Receives Dealer Contracts Valued at $3 Million
2010-07-27 09:00 ET - News Release
WILMINGTON, NC -- (MARKET WIRE) -- 07/27/10
Global Earth Energy, Inc. (OTCBB: GLER) announced that its wholly owned subsidiary RCI Solar, Inc., a North American provider of renewable energy products and services, has received commitments totaling $3 Million in solar energy product sales from its dealership network for accelerated delivery in 2010.
"In just six short months, our dealers have accounted for over $3 million in contractual sales. With a strong pipeline of additional contracts, RCI is on track to achieve record sales growth this year. We expect to generate total revenues of approximately $8.5 million to $10 million in 2010," said Mel Dick, president of RCI Solar, Inc.
"A well-established dealership network provides the expert implementation, installation and maintenance of all our systems. New business referrals from our dealerships can lead to additional revenue upside potential in the near future," said Syd Harland, CEO of Global Earth Energy, Inc.
You must be living off all those profits from JB :)
Sweet looking....playing long term??
ILVC on a tear here at the open!
I thought that company was dead in the water....looks like someone took it over!
ILVC upticking!!!!
Morning VZ3....enjoy the beautiful weekend?
You still following ILVC?
ABVV.011 +25% on excellent news!
ABVV (good for a few points)>>>> Abviva Announces Notice of Canadian Patent for Technology Used in Breast Cancer Diagnostics and Therapeutics
2010-07-26 09:55 ET - News Release
SANTA BARBARA, Calif., July 26 /PRNewswire-FirstCall/ -- Abviva, Inc. (Pink Sheets: ABVV), a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks.
The Mammastatin technology continues to increase its protection as evidenced by the granting of patents around its core technology. In recent months, the Japanese Patent Office issued two patents on the Mammastatin technology, and the Canadian patent will help protect the technology when it begins international expansion.
"The Company is very pleased with this notice of patent to be granted and believes that the issuance of the many patents will allow Abviva to expand internationally in years to come," said Barrett Evans, Abviva's CEO.
You need a vacation down south and regenerate your cells!!!
You still following that one? Was pm'd to jump on board on HRRN!
Good news form ASFX: American Scientific Resources Receives Commitment for $3 Million Financing
2010-07-21 10:06 ET - News Release
WESTON, Fla., July 21 /PRNewswire-FirstCall/ -- American Scientific Resources, Inc. (the "Company" or "ASR") (Pink Sheets: ASFX) announces today that the Company has received final commitment for a $3 million purchase order financing facility from Hartsko Financial Companies for the purpose of sales order fulfillment only.
American Scientific Resources has been a trusted source as an innovator in providing unique health and safety-related products that help children and their families lead healthier, happier and safer lives.
The Company's newly manufactured Non-Contact Thermometers including the Kidz-Med 5-in-1 consumer model and the VeraTemp 5-in-1 professional model, which utilize the latest in technology as a trauma-free, no-touch way to take a temperature quickly and easily, are scheduled to hit the market during the third quarter 2010.
Dr. Christopher Tirotta, CEO of American Scientific, commented, "Having non-dilutive financing available at this progressive stage in the Company's timeline not only improves our operational cash position but also provides assurance to current and new vendors that their PO's will be delivered on time."
He continues, "This is not a line of credit. We will begin using the financing very shortly and look forward to enjoying the stability this financing affords our growing company."
Hartsko will have a security interest in the financed inventory. ASR urges shareholders who would like to be on the Company's Newsletter E-mail List in order to receive all ASR updates to visit the ASR website homepage at www.americansci.com to sign-up.
About Hartsko Financial Companies
Hartsko Financial Companies specializes in purchase order financing for well-managed small to mid-sized companies. The company offers letter of credit financing, trade financing, obtaining sufficient capital, reduction of foreign risk, preservation of equity and speed of funding solutions. The company was founded in 2003 and is based in Bayside, New York. For more information on the company, visit www.hartsko.com.
She's starting to run!!!!!
What do you make of GLER's chart? Thanks!
GLER .036 x .0435 bids coming in!!!!
What do you make of todays news release re:ASFX?
I would consider it a BOUNCER PLAY!
LPIH>>>> Longwei Petroleum Approved for NYSE Amex Listing
2010-07-21 09:43 ET - News Release
Stock Will Trade Under Symbol "LPH"
TAIYUAN CITY, China, July 21 /PRNewswire-Asia-FirstCall/ -- Longwei Petroleum Investment Holding Ltd. (OTC Bulletin Board: LPIH) ("Longwei" or "the Company"), a leading oil and fuel wholesaler and distributor operating in Shanxi Province, China, announced today that the Company has received approval to list its common stock on NYSE AMEX. The Company will begin trading on the Amex on July 22, 2010 under the ticker symbol "LPH."
"We are excited to move to NYSE Amex and believe that this transition will bring greater value to our shareholders through increased investor visibility," Mr. Cai Yongjun, Chairman and CEO of Longwei, commented. "I can think of no better way to finish a strong fiscal year and jumpstart a new one than with this pivotal move to a senior exchange. We welcome the increased responsibility and accountability that the new listing will entail, and we see it as a validation of the trust and credibility that we have worked so hard to build with our investors. As a leading petroleum distributor in China, Longwei is strongly positioned to continue expanding its reach in the coming year. The transition to NYSE Amex enables us to increase awareness in the investment community and attract a larger, more diverse shareholder base. We would like to thank our shareholders, employees, and other stakeholders for their ongoing support as we move forward into what will undoubtedly be a record year for Longwei Petroleum."
LPIH got approve for NYSE listing!
What's the share structure on GLER?
UPDATE: Russian Missile Move Angers NATO Member Estonia
TALLINN, Estonia (AFP)--Baltic North Atlantic Treaty Organization member Estonia Tuesday slammed its neighbor and Soviet-era master Moscow for deploying missiles near its border, saying the move ran counter to fence-mending efforts.
"Russia's decision to position Iskander-class missiles on its western border is an alarming move," Estonian Foreign Minister Urmas Paet told AFP.
"While both sides speak of a desire to improve NATO-Russia relations and develop a partnership, this decision sends a negative signal."
Saturday, the commander of Russia's ground forces Alexander Postnikov told Moscow Echo radio that Iskander missile systems were being put into service in the military region around the city of Saint Petersburg, which lies some 140 kilometers from Estonia.
Postnikov said the missiles would mainly be based in that region, but added they could also be deployed elsewhere at short notice.
Russia and the U.S. have sparred over the U.S.'s plans to deploy anti-missile facilities in the former communist bloc, with Russia disputing the U.S. position that they are meant to ward off a potential threat from Iran.
Over the past year, however, NATO powerhouse the U.S. has been striving to "reset" its relationship with Russia and mend fences.
Staunch U.S. ally Estonia, a nation of 1.3 million people, was ruled by the Soviet Union for five decades but regained independence in 1991 when the bloc crumbled.
Estonia's ties with Russia have been rocky since then, and took a slide after it joined NATO and the European Union in 2004.
Russia has also warned that it could deploy Iskander missiles in its Baltic territory of Kaliningrad--which is sandwiched between Poland and Lithuania, both ex-communist NATO and E.U. members.
Iskander missiles have a range of 400 kilometers, Estonian Defense Minister Jaak Aaviksoo said.
The missiles deployed near St. Petersburg would therefore be able to reach not only Estonia but also Lithuania, their fellow NATO and EU member Latvia, and neutral EU member Finland.
"Such a step is incomprehensible, considering both present-day security threats and present relations between Russia and NATO," the Baltic News Service quoted Aaviksoo as saying.
"We are aware of the deployment of Iskander missiles in the immediate vicinity of Estonian and NATO borders and we keep very close watch on everything that goes on beyond our borders."
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=O7uBytix7oxhQ%2BEhFvTFcw%3D%3D. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
When's yoga classes starting?
Markets sucking!!!!
U know Crockodial Dundee???
Interesting....TRDX going for GOLD medal today!!!
SNMN (on radar)>>>> SNM Global Acquires $12,500,000 Small Hydro Technologies: Solutions for 1.7 Billion Without Power
2010-07-20 08:30 ET - News Release
LONDON -- (MARKET WIRE) -- 07/20/10
SNM Global Holdings (PINKSHEETS: SNMN) announced today the signing of an Intellectual Property (IP) Transfer Agreement with EQ-ip Equities (EQ-ip) under which the Company acquires, for development and international distribution, core Small & Micro Hydro technology from the EQ-ip extensive Intellectual Property Portfolio.
Access to electricity is one of the keys to development, as it provides light, heat and power for productive uses and communication. Today 1.7 billion people in developing countries do not have access to electricity, most of them living in rural areas.
The acquisition is valued at $12,500,000 purchased through an equity-building issuance of Preferred Stock and will create no debt for the Company.
This transaction is the first in a series of anticipated acquisitions under the Letter of Intent Agreement signed earlier this month with EQ-ip, a private technology and licensing holding company, to acquire, develop, distribute, and commercialize certain technologies from its portfolio.
EQ-ip specializes in clean energy technologies and solutions for emerging economies. SNM Global Holdings will acquire a portfolio of nascent and commercial technologies and Intellectual Property currently valued in excess of $49,000,000.
The Company has moved quickly to implement its recently announced operations, new business strategy and business plan, including its pioneering MicroTechnology Transfer Program and MicroEquity Partner Program.
SNM Global's MicroTechnology Transfer (mt2) Program and MicroEquity Partner Program enable the acquisition, development, and transfer of technologies that will provide for the betterment of society and provide the catalyst for emerging markets to leapfrog into the sustainable sectors that will drive the twenty-first century.
The newly acquired technologies and/or technology groups will be placed in the appropriate stage of the Company's MicroTechnology Transfer (mt2) Program and MicroEquity Partner Program; and will be introduced into SNM Global's distribution network for emerging market insertion and introduction.
The company believes its new and enhanced operational plan will provide significant revenue, equity growth, and serve the betterment of emerging economies.
SNM Global's MicroTechnology Transfer (mt2) Program is designed to further the commercialization of promising technologies that will benefit emerging markets in four key areas:
Energy -- Clean, Renewable, and Sustainable Energy
Health -- Better Health & Living
Water -- Drinking Water, Irrigation & Sanitation
Agriculture -- Green Biotechnology
The Company encourages collaboration with public, private and institutional partners in all phases of the development and technology transfer cycle; and accepts submissions from both collaborative development, distribution and inventor partners through the Collaboration Portal on its new website at www.SNMNglobal.com.
The company anticipates numerous technology and operational acquisitions and will continue to provide regular updates. The Company will soon announce additional details alongside full operational and financial disclosures.
More activity today on this one>>>> TRDX's Medical & Dental Products Division Enters Into Discussions for the Exclusive Distribution Rights for "Solecare(R)," an Innovative, Patent Pending Podiatry Product
2010-07-20 08:30 ET - News Release
LONG ISLAND, NY -- (MARKET WIRE) -- 07/20/10
SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. ("TRDX" or the "Company") (PINKSHEETS: TRDX), today announces that Preferred Distribution, Inc., the Company's medical and dental products subsidiary, has entered into discussion to acquire the exclusive distribution rights to Solecare®, an innovative, patent pending podiatry product.
Solecare® is a unique new product for the removal of calluses by pedicurists.
The Company expects discussions to result in an agreement in the near term.
Dr. Stahl, CEO of TRDX, commented: "I am excited at the opportunities that Solecare®'s products create in a new marketplace for SciMeDent."
About SCIMEDENT f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)
SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.
Cautionary Statement Regarding Forward-Looking Statements
A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company's business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.
Contact:
SciMeDent Health Corp. f/k/a Trend Exploration, Inc.
www.scimedenthealth.com
dmyers@cadenceconsultingllc.com
1-866-383-1374
Switch gears to TRDX, news back to back, lots of fuel in that big tank of theirs!!!!
HUge volume yesterday on ATWT.....TRDX moving higher today, check her out!
ARGC wants to continue into tommorrow!
You must be on summer hours lol!
PDPR going the opposite way!
STTN just released news!
TRDX Announces Negotiations Progressing Well With Genesis Biopharma; Definitive Agreement and Closing Expected Shortly
2010-07-19 08:30 ET - News Release
LONG ISLAND, NY -- (MARKET WIRE) -- 07/19/10
SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. ("TRDX" or the "Company") (PINKSHEETS: TRDX) today announces to its shareholders that its negotiations are progressing well towards a definitive agreement with Genesis Biopharma, Inc. ("Genesis") to acquire an exclusive worldwide sublicense for a new compound in development for the treatment of Painful Diabetic Neuropathy (PDN).
The Company expects the definitive agreement and subsequent closing to be finalized in a reasonably short period of time.
Dr. Jan Stahl, CEO of TRDX, commented: "We are pleased to be nearing completion of negotiations with Genesis. Additionally, plans for funding the development of Genesis' PDN solution are progressing. We look forward to the successful completion of these key milestones in the near future."
About Genesis Biopharma, Inc.
Genesis Biopharma, Inc. (www.genesisbiopharma.com) is a Canadian corporation founded in 2007 to exploit the commercial potential for the therapeutic use of peptidomimetic (modified amino acid peptides) compounds. Amino acids are the building blocks of proteins, which are found in every cell of every living thing on Earth. Proteins consist of extremely long and complex amino acid chains. In contrast, a peptide is a short string of amino acids, joined by chemical bonds (also called "amide bonds").
About SCIMEDENT f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)
SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.
Cautionary Statement Regarding Forward-Looking Statements
A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company's business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.
Contact:
SciMeDent Health Corp. f/k/a Trend Exploration, Inc.
www.scimedenthealth.com
dmyers@cadenceconsultingllc.com
1-866-383-1374
TRDX .035 up nicely!